Drug recall · July 26, 2023
Famotidine Tablets recall
Why: Labeling: Label Error on Declared Strength: some cartons labeled and containing 20 mg may have an external label placed on the side of the carton indicating strength as 10 mg.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Famotidine Tablets, USP, 20mg, 200-count bottle within a carton, Distributed by: Glenmark Therapeutics Inc., USA, Mahwah, NJ 07430, Made in India, NDC 72657-113-20.
- Lots / codes
FA2022001B, Exp 03/2025
- Quantity
- 19,968 bottles
- Company
- Glenmark Therapeutics, Inc., Mahwah, NJ
- Distribution
- Nationwide in the USA
- Initiated
- May 1, 2023 · Voluntary: Firm initiated
- Classified
- July 21, 2023
- Reported
- July 26, 2023
- Ended
- September 17, 2024
- How notified
- N/A
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Famotidine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.